Description

CJC1295 with DAC 2 mg Driada Medical has excellent results in releasing the analog growth hormone (GHRH) shown. In addition to the ability, to increase the secretion of IGF-I and growth hormone, This could also be achieved in significant quantities.

CJC1295 WITH DAC 2 MG DRIADA MEDICAL STUDIES

Recent research studies show, that CJC-1295 contains IGF-1- and stimulates HGH secretion, without increasing prolactin levels. Consequently, there is an increase in protein synthesis and significant fat loss.

The first clinical research studies on CJC-1295 were conducted in the mid-2000s. The aim of the peptide was to treat fatty deposits in AIDS patients. The hypothesis was based on fact, that high amounts of exogenous HGH promote fat loss. This clinical research was successful for the majority of subjects.

Studies have also shown, that by combining GHRP with CJC 1295 DAC a significant increase in the release of GH and IGF-1 occurs, without causing an increase in prolactin levels.

Facts about CJC1295 DAC 2 mg

Some good examples of a GHRH are Ipamorelin or GHRP-2.

CJC 1295 DAC is an exceptional peptide and is considered the best hGH secretagogue. His share of DAC (Drug Affinity Complex) increases the half-life by binding to serum albumin and also protects it from degradation.

CJC-1295 DAC und CJC-1295 (by others than Modified GRF 1-29 known) are both great growth hormone releasing hormones and their effect in the human body is identical. However, there are differences between these two peptides in terms of their half-life. While the modified GRF 1-20 a very short half-life of action (30 minutes) hat, The CJC-1295 DAC can last up to eight days and many scientists have reported, that the half-life of the modified GRF 1-29 far shorter is more natural, as it produces a short pulse of human growth hormone.